M. Weber

P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions

A. Bar-Or, H. Hartung, T. Derfuss, 2020, Clinical Neurophysiology.